Metastatic

Also known as: Metastatic neoplasm / Secondary malignant neoplasm of unspecified site / Neoplasm, metastatic (morphologic abnormality) / Metastatic disease

Drug Trials

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB11714	Durvalumab	1	Completed	1
DB17573	Evorpacept	1	Recruiting	1
DB00544	Fluorouracil	1	Completed	1
DB00762	Irinotecan	1	Completed	1
DB00650	Leucovorin	1	Completed	1
DB17169	MTI-201	1	Recruiting	1
DB01229	Paclitaxel	1	Withdrawn	1
DB14962	Trastuzumab deruxtecan	1	Recruiting	1
DB16342	Trastuzumab duocarmazine	1	Withdrawn	1
DB11771	Tremelimumab	1	Completed	1
DB11652	Tucatinib	1	Recruiting	1
DB05294	Vandetanib	1	Completed	1
DB15471	Zanidatamab	1	Recruiting	1
DB01101	Capecitabine	1 / 2	Recruiting	1
DB12130	Lorlatinib	1 / 2	Recruiting	1
DB05578	Ramucirumab	1 / 2	Recruiting	1
DB11767	Sarilumab	1 / 2	Recruiting	1
DB00188	Bortezomib	2	Completed	1
DB16741	Bortezomib D-mannitol	2	Completed	1
DB01101	Capecitabine	2	Recruiting	1
DB00002	Cetuximab	2	Completed	1
DB00515	Cisplatin	2	Completed	1
DB01248	Docetaxel	2	Completed	1
DB16891	ENMD-981693	2	Completed	1
DB00441	Gemcitabine	2	Completed	2
DB00441	Gemcitabine	2	Recruiting	1
DB00762	Irinotecan	2	Unknown Status	1
DB05941	Leronlimab	2	Withdrawn	1
DB14123	Menthol	2	Completed	1
DB00526	Oxaliplatin	2	Completed	1
DB01229	Paclitaxel	2	Recruiting	1
DB00860	Prednisolone	2	Completed	1
DB08896	Regorafenib	2	Withdrawn	1
DB15765	Sintilimab	2	Recruiting	1
DB15106	Surufatinib	2	Recruiting	1
DB05294	Vandetanib	2	Completed	1
DB00851	Dacarbazine	3	Completed	1
DB11689	Selumetinib	3	Completed	1
DB00112	Bevacizumab	Not Available	Completed	1
DB01229	Paclitaxel	Not Available	Completed	1
DB11942	Selinexor	Not Available	Active Not Recruiting	1